跳至主要内容
临床试验/NCT06995391
NCT06995391招募中不适用

Digitally Rendered Interventions And Knowledge To Limit Ethanol-Associated Atrial Fibrillation Severity

University of California, San Francisco2 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2025年4月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
1,000
试验地点
2
主要终点
Change in atrial fibrillation severity at one year

研究概览

简要总结

Per the 2021 National Survey on Drug Use and Health administered by the U.S. Department of Health and Human Services, 85% of all American adults consume alcohol. Atrial fibrillation (AF) is the most common arrhythmia, affecting more than 10 million individuals in U.S., comprising 4.5% of the adult population. Although alcohol abstinence clearly reduces AF in heavy drinkers, observational data comparing the health effects of limited consumption versus abstention are conflicting.

The Mediterranean diet is one of the few that has demonstrated clear cardiovascular benefits in a randomized study-this diet allows for the consumption of red wine (or high polyphenol/ low alcohol alcohol), generally not more than one drink in 24 hours, with meals, avoiding spirits and binge drinking. The effect of the "Mediterranean drinking pattern" on AF risk compared to alcohol abstinence remains unknown.

This single center, randomized, controlled trial aims to compare the effects of a digital health intervention to encourage durable alcohol abstinence versus allowing guideline-adherent moderate alcohol consumption on AF severity. The knowledge gained from this study may be used to determine optimal thresholds for alcohol use among AF patients.

详细描述

This single center, randomized, controlled trial aims to compare the effects of a digital health intervention to encourage durable alcohol abstinence versus allowing guideline-adherent moderate alcohol consumption on AF severity. Any English-speaking individual over the age of 21, with a diagnosis of paroxysmal or persistent AF, who consumes alcohol at least once per month and is willing to receive messaging encouraging alcohol abstinence, will be eligible to participate in this study.

Participants will be randomly assigned to one of two digital health interventions for one year. Those randomly assigned to the Contemporary Guideline-Adherence Arm will receive weekly app and text-based messaging encouraging them not to exceed guideline-directed amounts of alcohol, as well as messaging explaining that abstinence is acceptable and may be the best way to avoid AF and that, if a participant decides to consume alcohol, a Mediterranean drinking pattern may be the most healthy. Those randomly assigned to the Alcohol Abstinence Arm will receive weekly app- and text-based messaging encouraging avoidance of all alcohol consumption. Throughout the study, alcohol consumption (or abstinence) and atrial fibrillation episodes and severity will be assessed by serial surveys. Abstinence will also be objectively assessed via urine ethyl glucuronide (EtG) tests and a blood test for phosphatidylethanol (PEth) in randomly selected participants in each Arm. A minimum of 1,000 participants and up to 10,000 participants will be enrolled in the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Are age 21 years or older
  • •Have a smartphone
  • •Are able to use the Eureka mobile application
  • •Have a history of paroxysmal or persistent atrial fibrillation (AF)
  • •Have consumed alcohol at least once per month on average in the past year
  • •Willing to receive messaging encouraging alcohol abstinence

排除标准

  • •Non-english speaker
  • •Currently pregnant or trying to get pregnant
  • •A healthcare professional's instruction to avoid alcohol (for any reason)
  • •Currently incarcerated
  • •Permanent AF (meaning a medical determination has been made that sinus rhythm would definitely never be pursued in this patient)
  • •Are unable to read or sign to provide informed consent

研究组 & 干预措施

Contemporary Guideline-Adherence

Experimental

Participants randomized to Contemporary Guideline-Adherence will receive weekly app and text-based messaging encouraging them not to exceed guideline-directed amounts of alcohol, as well as messaging explaining that abstinence is acceptable and may be the best way to avoid AF and that, if a participant decides to consume alcohol, a Mediterranean drinking pattern may be the most healthy. Alcohol consumption (or abstinence) and AF episodes and severity will be assessed by serial surveys. Abstinence will also be objectively assessed via urine ethyl glucuronide (EtG) tests and a blood test for phosphatidylethanol (PEth) in randomly selected participants.

干预措施: Contemporary Guideline-Adherence (Behavioral)

Alcohol Abstinence

Experimental

Participants randomized to Alcohol Abstinence will receive weekly app and text-based messaging encouraging avoidance of all alcohol consumption. Those assigned to this arm will also have the option to opt-in or decline to participate in additional messaging and surveys discouraging the purchase of alcohol triggered by visits to establishments that sell alcohol (bars and liquor stores) for the first month of the study. Alcohol consumption (or abstinence) and AF episodes and severity will be assessed by serial surveys. Abstinence will also be objectively assessed via urine ethyl glucuronide (EtG) tests and a blood test for phosphatidylethanol (PEth) in randomly selected participants.

干预措施: Alcohol Abstinence (Behavioral)

结局指标

主要结局

Change in atrial fibrillation severity at one year

时间窗: From baseline to one year of study participation.

The primary outcome will be change in atrial fibrillation severity at one year, defined by a change in the Atrial Fibrillation Effect on Quality-of-Life Questionnaire (AFEQT) score from baseline to one year associated with alcohol abstinence. Based on previously reported values of clinically relevant change in AFEQT score (PMID 31092022), the investigators estimate the change in mean AFEQT score from baseline to 1 year to be 5.4±17.03 in the Alcohol Abstinence group and 0.2±15.17 in the Contemporary Guideline-Adherence group, giving a 5.2 difference between the two groups. The investigators estimate that 1,000 patients would provide \~99% power to detect this difference with as much as 30% overall attrition, and 30% crossover from abstinence to drinking regularly and 20% crossover from drinking regularly to abstinence.

次要结局

  • Atrial fibrillation burden at one year, quantified by Apple Watch(At one year of study participation.)
  • Total number of negative urine ethyl glucuronide tests at one year(From baseline to one year of study participation.)
  • Results of the phosphatidylethanol test at one year(At one year of study participation.)
  • Atrial fibrillation burden at one year, quantified by a cardiac device(At one year of study participation.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

已完成
不适用
Digital mental health literacy program for first-year medical students in FinlandStressPrevention of mental health problems by increasing students' knowledge about mental health, improving their attitudes towards mental health problems, enhancing help-seeking behavior as well as promotion of wellbeing and stress management.Mental and Behavioural Disorders
ISRCTN10565335Academy of Finland186
已完成
不适用
Digital Health Intervention On Awareness Of Vaccination Against Influenza Among Adults With DiabetesDiabetes Mellitus Self Management EducationDiabetes
NCT06840236LabStyle Innovations Ltd.8,431
已完成
不适用
Sharing Stories: A digital intervention for caregivers with young children in the COVID-19 era to promote child social, emotional and language development, responsive parenting and parental mental wellbeing in Zambia, Tanzania, and UgandaChild social, emotional and language development, responsive parenting, parental mental wellbeing
ISRCTN77689525Stellenbosch University734
终止
2 期
Clinical Impact and Utility of Digital Health Solutions in Participants Receiving Systemic Treatment in Clinical PracticeCancer
NCT05694013Hoffmann-La Roche49
已完成
不适用
A randomised controlled trial and parallel process evaluation to determine whether CFHealthHub, an intervention to help CF patients build better treatment habits, offers any benefit over usual care to adults with CFSpecialty: Respiratory disorders, Primary sub-specialty: Respiratory disordersUKCRC code/ Disease: Congenital Disorders/ Congenital malformations of the respiratory systemRespiratoryCongenital Disorders/ Congenital malformations of the respiratory system
ISRCTN55504164Sheffield Teaching Hospitals NSH Foundation Trust608